» Articles » PMID: 15389911

Presentation and Pattern of Symptoms in 382 Patients with Glanzmann Thrombasthenia in Iran

Overview
Journal Am J Hematol
Specialty Hematology
Date 2004 Sep 25
PMID 15389911
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Glanzmann thrombasthenia (GT) is a rare autosomal recessive disease characterized by prolonged bleeding time with normal platelet count and morphology. It is caused by the quantitative or qualitative deficiency of the platelet glycoprotein IIb-IIIa. In 382 Iranian patients with GT diagnosed at a single center during the period 1969-2001, consanguinity between parents was 86.6%, in accord with the high frequency of intrafamilial marriages in Iran. Almost all patients had had abnormal mucocutaneous bleeding (epistaxis and gum bleeding); at follow-up, 4/5 of the patients had been transfused at least once to control hemorrhagic episodes. As expected, almost all the patients had a normal platelet count while the leukocyte count was increased in 19.3%. Among women, an unexpected low rate of pregnancies was observed.

Citing Articles

Epidemiological and clinical characteristics of children and young adults with Glanzmann's thrombasthenia in upper Egypt: a multicenter cross-sectional study.

Khalifa G, El-Sayed A, Elmasry Z, Elsayh K, Atwa Z, Morgan D Ann Hematol. 2025; .

PMID: 40074839 DOI: 10.1007/s00277-025-06290-5.


A bispecific antibody approach for the potential prophylactic treatment of inherited bleeding disorders.

Gandhi P, Zivkovic M, Ostergaard H, Bonde A, Elm T, Lovgreen M Nat Cardiovasc Res. 2024; 3(2):166-185.

PMID: 39196196 PMC: 11358003. DOI: 10.1038/s44161-023-00418-4.


Catheter Intervention in a Patient with Intracranial Aneurysms and Glanzmann Thrombasthenia Caused by a Novel Homozygous Likely Pathogenic Variant in the Gene.

Boeckelmann D, von Dobeneck L, Henkes H, Eichler H, Glonnegger H, Zieger B Diseases. 2024; 12(7).

PMID: 39057107 PMC: 11275344. DOI: 10.3390/diseases12070136.


characterization of rare anti-αβ isoantibodies produced by patients with Glanzmann thrombasthenia that severely block fibrinogen binding and generate procoagulant platelets via complement activation.

Lee C, Huguenin Y, Pillois X, Moulieras M, Marcy E, Whittaker S Res Pract Thromb Haemost. 2024; 8(1):102253.

PMID: 38268518 PMC: 10805943. DOI: 10.1016/j.rpth.2023.102253.


Glanzmann Thrombasthenia Associated with Siderotic Synovitis and Arthropathy: A Case Report.

Alawad M, Abu-Tineh M, Alshurafa A, Al-Taie A, Yousaf A, Yassin M J Blood Med. 2023; 14:563-567.

PMID: 37941894 PMC: 10629506. DOI: 10.2147/JBM.S418937.